Post- End- Expiratory Pressure Affect the Alveolar Heterogeneity in Moderate and Sever ARDS Patients
NCT ID: NCT03763890
Last Updated: 2022-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2018-09-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of EIT-guided PEEP Titration on the Prognosis of Patients with Moderate to Severe ARDS
NCT05207202
A Comparison of Optimal PEEP Determination Guided by EIT and Conventional Protective Ventilation Tool in ARDS Patients
NCT03498807
Early PP Monitored by EIT in Patients With ARDS
NCT05822869
Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes
NCT06958770
Effect of Electric Impedance Tomography-Guided PEEP Titration
NCT05736185
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Post-end-Expiratory pressure
Titrate the PEEP from 24 cmH2O to 6 cmH2O, 2 cmH2O/step and record EIT, trans-pulmonary pressure, hemodynamic parameter and Blood-gas analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Moderate or sever ARDS in 2012 \<Berlin definition\>;
3. Applied mechanical ventilation;
4. Consent signed.
Exclusion Criteria
2. Cardiogenic edema;
3. Sever neutropenia(\<500/mm3);
4. Hemodynamic astatic: DOPA or Dobutamine \>15 µg/kg/ min; NE \> 15ug /min;
5. GCS coma score ≤12;
6. Thoracic injury or surgery patients contradict EIT ;
7. Refuse to join in trail;
8. Included in other clinical trail。
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southeast University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ling Liu
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
haibo qiu, PhD
Role: STUDY_DIRECTOR
Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Zhong-Da Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20181129PEEP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.